Low molecular proanthocyanidin dietary biofactor Oligonol: Its modulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention potentials.
Interdisciplinary research endeavors are directed at understanding the molecular mechanisms of neurodegenerative and chronic diseases that affect human lifestyle. Hence the potential for developing medicinal herb-derived and food plant-derived prophylactic agents directed at neurological, metabolic, cardiovascular and psychiatric disorders abounds. Oligonol is a novel technology product emanating from the oligomerization of polyphenols, typically proanthocyanidin from a variety of fruits (grapes, apples, persimmons etc.) that has optimized bioavailability. It is an optimized phenolic product containing catechin-type monomers and oligomeric proanthocyanidins, the easily absorbed forms. Typically the constituents of Oligonol are 15-20% monomers, 8-12% dimers and 5-10% trimers. Supplementation of mice with Oligonol prior to the administration of ferric-nitrilotriacetic complex (a Fenton chemistry model) significantly reduced the extent of lipid peroxidation in the kidney, brain and liver. Oligonol triggers apoptosis in the MCF-7 and MDA-MB-231 breast cancer cells through modulation of the pro-apoptotic Bcl-2 family of proteins and the MEK/ERK signaling pathway, an observation suggesting its important chemopreventive effects. The senescence-accelerated strain of mice (SAM) are models of senescence acceleration and geriatric disorders which exhibit learning and memory deficits and enhanced production or defective control of oxidative stress leading.
Aruoma
Okezie I
OI
Faculty of Health and Social Care, London South Bank University, 103 Borough Road, London SE1 0AA, UK. aruomaoi@lsbu.ac.uk
Sun
Buxiang
B
Fujii
Hajime
H
Neergheen
Vidushi S
VS
Bahorun
Theeshan
T
Kang
Kyung-Sun
KS
Sung
Mi-Kyung
MK
D000818:Animals; D001682:Biological Availability; D002392:Catechin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D018890:Chemoprevention / Q000379:methods; D019587:Dietary Supplements; D006801:Humans; D008970:Molecular Weight; D018696:Neuroprotective Agents / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects; D010636:Phenols / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D044945:Proanthocyanidins / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*
D018696:Neuroprotective Agents; D010636:Phenols; D044945:Proanthocyanidins; C514283:oligonol; C013221:proanthocyanidin; D002392:Catechin